Literature DB >> 18222122

Involvement of heparanase in migration of microglial cells.

Hisaaki Takahashi1, Hiroaki Matsumoto, Anna Smirkin, Tomohide Itai, Yoshio Nishimura, Junya Tanaka.   

Abstract

Heparanase, a matrix-degrading enzyme that cleaves heparan sulfate side chains from heparan sulfate proteoglycans (HSPGs), has been shown to facilitate cell invasion, migration, and extravasation of metastatic tumor cells or immune cells. In this study, the expression and functions of heparanase were investigated using rat primary cultured microglia, the resident macrophages in the brain. The microglia were found to express heparanase mRNA and protein. Microglia treated with lipopolysaccharide (LPS) were activated, expressed induced nitric oxide synthase and elevated the expression of heparanase. Heparanase has two molecular weights: a 65 kDa latent form and an active 50 kDa. Both forms were expressed by LPS-treated activated microglia; however, untreated microglia primarily expressed the latent form. Cell lysates from microglia actually degraded Matrigel containing HSPG. Heparanase was colocalized with the actin cytoskeleton in microglial leading edges or ruffled membranes. Microglia transmigrated through a Matrigel-coated pored membrane. This process was inhibited by SF-4, a specific heparanase inhibitor, in a concentration-dependent manner. Degraded HSPG was generated when microglia transmigrated through the coated membrane, and this was also inhibited by SF-4. The results suggest the involvement of heparanase in the migration or invasion of microglia or brain macrophages across basement membrane around brain vasculature.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18222122     DOI: 10.1016/j.bbagen.2007.12.014

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Heparanome-Mediated Rescue of Oligodendrocyte Progenitor Quiescence following Inflammatory Demyelination.

Authors:  Darpan Saraswat; R Ross Welliver; Roopa Ravichandar; Ajai Tripathi; Jessie J Polanco; Jacqueline Broome; Edward Hurley; Ranjan Dutta; M Laura Feltri; Fraser J Sim
Journal:  J Neurosci       Date:  2021-01-20       Impact factor: 6.167

2.  Iba1(+)/NG2(+) macrophage-like cells expressing a variety of neuroprotective factors ameliorate ischemic damage of the brain.

Authors:  Anna Smirkin; Hiroaki Matsumoto; Hisaaki Takahashi; Akihiro Inoue; Masahiko Tagawa; Shiro Ohue; Hideaki Watanabe; Hajime Yano; Yoshiaki Kumon; Takanori Ohnishi; Junya Tanaka
Journal:  J Cereb Blood Flow Metab       Date:  2009-10-28       Impact factor: 6.200

3.  A cytokine mixture of GM-CSF and IL-3 that induces a neuroprotective phenotype of microglia leading to amelioration of (6-OHDA)-induced Parkinsonism of rats.

Authors:  Mohammed Emamussalehin Choudhury; Kana Sugimoto; Madoka Kubo; Masahiro Nagai; Masahiro Nomoto; Hisaaki Takahashi; Hajime Yano; Junya Tanaka
Journal:  Brain Behav       Date:  2011-09       Impact factor: 2.708

4.  The microglial activation state regulates migration and roles of matrix-dissolving enzymes for invasion.

Authors:  Starlee Lively; Lyanne C Schlichter
Journal:  J Neuroinflammation       Date:  2013-06-21       Impact factor: 8.322

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.